Patents by Inventor Blaise Corthesy

Blaise Corthesy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ALLERGEN PEPTIDE FRAGMENTS AND USE THEREOF FOR TREATMENT OF DUST MITE ALLERGIES
    Publication number: 20120100167
    Abstract: The present invention relates generally to in vivo methods and compositions designed for allergen specific immunotherapy. The compositions include contiguous overlapping peptide fragments which together form an entire amino acid sequence of an allergen.
    Type: Application
    Filed: October 28, 2011
    Publication date: April 26, 2012
    Applicant: ANERGIS S.A.
    Inventors: Francois Spertini, Blaise Corthesy
  • PROBIOTICS, SECRETORY IGA AND INFECTION
    Publication number: 20120014963
    Abstract: The present invention relates generally to the field of nutrition, health and wellness. In particular the present invention relates to probiotics and ways to increase their effectiveness. One embodiment of the present invention relates to a combination of probiotics with secretory IgA and possible uses of this combination. For example a use of a composition comprising secretory IgA and at least one probiotic for the preparation of a product to treat or prevent infection is disclosed.
    Type: Application
    Filed: June 16, 2009
    Publication date: January 19, 2012
    Applicant: NESTEC S.A.
    Inventors: Jalil Benyacoub, Blaise Corthesy, Stephanie Blum-Sperisen, Laurent Favre
  • Allergen peptide fragments and use thereof
    Patent number: 8075897
    Abstract: The present invention relates generally to in vivo methods and compositions designed for allergen specific immunotherapy. The compositions include contiguous overlapping peptide fragments which together form an entire amino acid sequence of an allergen.
    Type: Grant
    Filed: September 14, 2005
    Date of Patent: December 13, 2011
    Assignee: Anergis S.A.
    Inventors: Francois Spertini, Blaise Corthesy
  • PROBIOTICS, SECRETORY IgA AND INFLAMMATION
    Publication number: 20110268743
    Abstract: The present invention relates generally to the field of nutrition, health and wellness. In particular the present invention relates to probiotics and ways to increase their effectiveness. One embodiment of the present invention relates to a combination of probiotics with SIgA and possible uses of this combination. For example a use of a composition comprising SIgA and at least one probiotic for the preparation of a product to treat or prevent inflammation is disclosed.
    Type: Application
    Filed: June 16, 2009
    Publication date: November 3, 2011
    Applicant: NESTEC S.A.
    Inventors: Jalil Benyacoub, Blaise Corthesy, Stephanie Blum-Sperisen, Laurent Favre
  • Allergen peptide fragments and use thereof
    Patent number: 7923209
    Abstract: The present invention relates generally to in vivo methods and compositions designed for allergen specific immunotherapy. The compositions include contiguous overlapping peptide fragments which together form an entire amino acid sequence of an allergen.
    Type: Grant
    Filed: March 12, 2004
    Date of Patent: April 12, 2011
    Assignee: Anergis, S.A.
    Inventors: Francois Spertini, Blaise Corthesy
  • Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions
    Patent number: 7498162
    Abstract: The present invention pertains to novel strains of lactic acid bacteria that are capable to reduce an individual's tendency to mount allergic reactions. In particular, the present invention relates to the generation of lactic acid bacteria strains that express proteins including tolerogenic peptides and the use thereof in reducing an individual's tendency to mount allergic reactions. The invention also pertains to food or pharmaceutical compositions containing said micro-organisms or active fractions thereof.
    Type: Grant
    Filed: September 21, 2001
    Date of Patent: March 3, 2009
    Assignee: Nestec S.A.
    Inventors: Jacques Edouard Germond, Blaise Corthesy, Beat Mollet, Rodolphe Fritsche
  • Allergen peptide fragments and use thereof
    Publication number: 20070110673
    Abstract: The present invention relates generally to in vivo methods and compositions designed for allergen specific immunotherapy. The compositions include contiguous overlapping peptide fragments which together form an entire amino acid sequence of an allergen.
    Type: Application
    Filed: September 14, 2005
    Publication date: May 17, 2007
    Inventors: Francois Spertini, Blaise Corthesy
  • Allergen peptide fragments and use thereof
    Publication number: 20040241178
    Abstract: The present invention relates generally to in vivo methods and compositions designed for allergen specific immunotherapy. The compositions include contiguous overlapping peptide fragments which together form an entire amino acid sequence of an allergen.
    Type: Application
    Filed: March 12, 2004
    Publication date: December 2, 2004
    Inventors: Francois Spertini, Blaise Corthesy
  • Lactic acid bateria capable of reducing an individual's tendency to develop allergic reactions
    Publication number: 20040071714
    Abstract: The present invention pertains to novel strains of lactic acid bacteria that are capable to reduce an individual's tendency to mount allergic reactions. In particular, the present invention relates to the generation of lactic acid bacteria strains that express proteins including tolerogenic peptides and the use thereof in reducing an individual's tendency to mount allergic reactions. The invention also pertains to food or pharmaceutical compositions containing said micro-organisms or active fractions thereof.
    Type: Application
    Filed: September 8, 2003
    Publication date: April 15, 2004
    Inventors: Jacques Edouard Germond, Blaise Corthesy, Beat Molltet, Rodolphe Fritsche